FLT3 Inhibitors in Acute Myeloid Leukemia: Choosing the Best When the Optimal Does Not Exist

American Journal of Hematology - United States
doi 10.1002/ajh.25027
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2011English

The Evolving Role of FLT3 Inhibitors in Acute Myeloid Leukemia: Quizartinib and Beyond

Therapeutic Advances in Hematology
Hematology
2014English

FLT3-TKD Mutation in Childhood Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2003English

CDK9 Inhibitors in Acute Myeloid Leukemia

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2018English

DNA Damage on the DOCK in FLT3-ITD-driven Acute Myeloid Leukemia

Haematologica
Hematology
2019English

8-Chloro-Adenosine Activity in FLT3-ITD Acute Myeloid Leukemia

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2019English

Targeting BTK for the Treatment of FLT3-ITD Mutated Acute Myeloid Leukemia

Scientific Reports
Multidisciplinary
2015English

Novel Mutations in the FLT3 Gene in Adult Patients With Refractory Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2004English

Rational for Targeting the Hedgehog Signalling Pathway in Acute Myeloid Leukemia With FLT3 Mutation

Annals of Translational Medicine
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy